Search results
Get the latest KMPH stock quote, news, analysis and more on Yahoo Finance. Compare with interactive charts and historical data.
KemPharm, Inc. Common Stock (KMPH) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.
Kempharm Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
May 17, 2022 · KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares...
May 15, 2022 · KemPharm plans to refile the New Drug Application (NDA) for arimoclomol in NPC with the U.S. Food and Drug Administration (FDA) as early as the First Quarter of 2023. Conference call and live ...
Helping drag down the group were shares of KemPharm (KMPH), off about 53.5% and shares of Endo International (ENDP) down about 39.9% on the day.
Find the latest historical data for KemPharm, Inc. Common Stock (KMPH) at Nasdaq.com.
Looking to buy KemPharm Stock? View today's KMPH stock price, trade commission-free, and discuss KMPH stock updates with the investor community.
Apr 13, 2021 · In this article, I will explain why the amendment is a good thing and why KemPharm stock (KMPH) is a buying opportunity.
Nov 9, 2022 · As of September 30, 2022, total shares of common stock outstanding was 34,501,144 shares, and fully diluted common shares outstanding was 47,076,872 shares, which included 4,252,600 shares issuable upon exercise of warrants.
